6533b7d8fe1ef96bd126a52d
RESEARCH PRODUCT
Atypical epithelial hyperplasia of the breast: state of the art.
Susie BrousseAurélie CauchoisCharles CoutantJean LevêqueAdelaïde RacinLudivine DionVincent LavouéFrançoise Beltjenssubject
RiskPathologymedicine.medical_specialtysurgical excisionBiopsyLobular carcinoma[SDV.CAN]Life Sciences [q-bio]/CancerBreast NeoplasmsAtypical ductal hyperplasiacore needle biopsy030218 nuclear medicine & medical imagingatypical lobular hyperplasia03 medical and health sciences0302 clinical medicineBreast cancerbreast cancerBiopsyAtypiaMedicineHumansPharmacology (medical)Epithelial hyperplasiaBreastskin and connective tissue diseaseslobular carcinoma in situHyperplasiamedicine.diagnostic_testbusiness.industryHyperplasiamedicine.diseaseImmunohistochemistry3. Good healthOncologycolumnar cell lesions with atypia030220 oncology & carcinogenesisImmunohistochemistryFemalebusinesslobular neoplasiaPrecancerous ConditionsLobular Neoplasiadescription
International audience; Introduction: Atypical epithelial hyperplasia (AEH) of the breast is considered benign histological lesions with breast cancer risk. This review focuses on clinical signification and management of AEH that remains controversial. Areas covered: A review of published studies was performed using medline database. In this review, we fully describe the current evidence available. In particular, we describe 1) data from immunohistochemistry and molecular studies that suggest AEH is a precursor of breast cancer; 2) epidemiological studies demonstrate low rate of breast cancer in women with AEH; 3) surgical excision is necessary after diagnosis of AEH, such as lobular carcinoma in situ or atypical ductal hyperplasia, on core needle biopsy; 4) although current recommendations are evolving to fewer (if not no) excisions for flat epithelial with atypia and classic lobular neoplasia found on percutaneous biopsy (without radiologic indications for excision). Expert commentary: HEA management steel need prospective evidences, but recent retrospective data give some clue for less invasive management for some of HEA. © 2016 Informa UK Limited, trading as Taylor & Francis Group.
year | journal | country | edition | language |
---|---|---|---|---|
2016-07-05 | Expert review of anticancer therapy |